StockData
Neuphoria Therapeutics Inc. logo

Neuphoria Therapeutics Inc. (NEUP) stock

NEUPNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-K on Sep 18, 2026Score 5/30
$2.27−0.21 (-8.47%)

Close on Nov 17, 2026Market cap $68.24KP/E –Yield –

Neuphoria Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Neuphoria Therapeutics's pe ratio was 0.0× on Jul 31, 2025.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jul 31, 20250.0×–

More Neuphoria Therapeutics figures

See a number that looks wrong?